Christos Coutifaris
Director/Board Member at American Society for Reproductive Medicine
Profile
Christos Coutifaris is a Member of the Board of Directors at the American Society for Reproductive Medicine.
He was previously a Member of the Clinical Advisory Board at Nora Therapeutics, Inc.
Christos Coutifaris active positions
Companies | Position | Start |
---|---|---|
American Society for Reproductive Medicine
American Society for Reproductive Medicine Miscellaneous Commercial ServicesCommercial Services The American Society for Reproductive Medicine engages in multidisciplinary information, education, advocacy, and standards in the field of reproductive medicine. The non-profit company is based in Birmingham, AL. The CEO of the company is Richard Reindollar. | Director/Board Member | - |
Former positions of Christos Coutifaris
Companies | Position | End |
---|---|---|
Nora Therapeutics, Inc.
Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nora Therapeutics, Inc. develops therapeutics to address clinical unmet needs in reproductive medicine. Its's lead product NT100, seeks to improve pregnancy outcomes in women undergoing in vitro fertilization or who have suffered recurrent spontaneous miscarriages. The company was founded by Darryl L. Carter and Chris B. McClain in 2007 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
American Society for Reproductive Medicine
American Society for Reproductive Medicine Miscellaneous Commercial ServicesCommercial Services The American Society for Reproductive Medicine engages in multidisciplinary information, education, advocacy, and standards in the field of reproductive medicine. The non-profit company is based in Birmingham, AL. The CEO of the company is Richard Reindollar. | Commercial Services |
Nora Therapeutics, Inc.
Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nora Therapeutics, Inc. develops therapeutics to address clinical unmet needs in reproductive medicine. Its's lead product NT100, seeks to improve pregnancy outcomes in women undergoing in vitro fertilization or who have suffered recurrent spontaneous miscarriages. The company was founded by Darryl L. Carter and Chris B. McClain in 2007 and is headquartered in Palo Alto, CA. | Health Technology |
- Stock Market
- Insiders
- Christos Coutifaris